The US Food and Drug Administration (FDA) has granted an approval to Canon USA's CR-2 Plus Digital Non-Mydriatic Retinal camera useful for ophthalmic professionals.
The CR-2 Plus provides fundus auto fluorescence (FAF) Photography in a non-mydriatic mode, that monitors macular waste materials and delivers both red-free and cobalt digital filters that are useful in evaluating the vascular and nerve fiber layers.
The CR-2 Plus also features EOS camera technology with 18 megapixels to capture detailed diagnostic images of the retina.
The Retinal camera unit also provides low-flash intensity which aids in minimizing pupil constriction, while shortening the time required for taking multiple pictures.
The CR-2 PLUS also uses the company’s retinal imaging control software (RICS) which allows images to be captured, processed and sent to a permanent storage database as DICOM3 or JPEG files, or printed through Canon imagePress product equipment.